Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 201,184 | 141,040 | 68,981 | 139,585 | 124,941 |
| Depreciation Amortization | 75,203 | 49,836 | 24,734 | 87,747 | 63,075 |
| Income taxes - deferred | 7,888 | 7,233 | 5,407 | -27,431 | -6,023 |
| Accounts receivable | -60,930 | -9,347 | -3,637 | -15,549 | -32,710 |
| Accounts payable and accrued liabilities | 11,229 | -175 | -2,303 | 19,091 | 12,198 |
| Other Working Capital | -76,460 | -41,755 | -53,524 | 29,263 | -6,856 |
| Other Operating Activity | 64,441 | 2,595 | 8,776 | 119,458 | 75,519 |
| Operating Cash Flow | $222,555 | $149,427 | $48,434 | $352,164 | $230,144 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,943 | -1,050 | -1,050 | 26,693 | 26,693 |
| PPE Investments | -31,338 | -16,238 | -6,070 | -44,301 | -32,985 |
| Net Acquisitions | N/A | N/A | N/A | -225,352 | -9,765 |
| Purchase Of Investment | -25,000 | -25,000 | N/A | -556 | -556 |
| Investing Cash Flow | $-78,281 | $-42,288 | $-7,120 | $-243,516 | $-16,613 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 90,000 | 50,000 | 10,000 | 256,000 | N/A |
| Debt Repayment | -172,375 | -109,250 | -51,125 | -271,500 | -141,375 |
| Common Stock Issued | 68,346 | 56,500 | 37,880 | 65,092 | 54,992 |
| Common Stock Repurchased | -102,132 | -41,294 | 0 | -43,178 | -43,178 |
| Dividend Paid | -37,646 | -25,069 | -12,493 | -49,622 | -37,174 |
| Other Financing Activity | -23,318 | -23,947 | -23,946 | -19,343 | -13,504 |
| Financing Cash Flow | $-177,125 | $-93,060 | $-39,684 | $-62,551 | $-180,239 |
| Exchange Rate Effect | -5,419 | -1,325 | -4,400 | 6,369 | 6,219 |
| Beginning Cash Position | 199,091 | 199,091 | 199,091 | 146,625 | 146,625 |
| End Cash Position | 160,821 | 211,845 | 196,321 | 199,091 | 186,136 |
| Net Cash Flow | $-38,270 | $12,754 | $-2,770 | $52,466 | $39,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | 222,555 | 149,427 | 48,434 | 352,164 | 230,144 |
| Capital Expenditure | -31,338 | -16,238 | -6,070 | -44,301 | -32,985 |
| Free Cash Flow | 191,217 | 133,189 | 42,364 | 307,863 | 197,159 |